Literature DB >> 21507335

Regional cerebral blood flow and aberrant motor behaviour in Alzheimer's disease.

Thomas J Reilly1, Roger T Staff, Trevor S Ahearn, Peter Bentham, Claude M Wischik, Alison D Murray.   

Abstract

Aberrant motor behaviour (AMB) in Alzheimer's disease shares behavioural correlates with obsessive compulsive disorder (OCD). We investigated whether AMB was also comparable in terms of metabolic activity in the orbitofrontal cortex (OFC), an area shown to be hyperactive in OCD. In this study 135 patients meeting research criteria for Alzheimer's disease were identified from a database of patients recruited as part of a phase II drug trial. These patients were assessed using the Neuropsychiatric Inventory, the Alzheimer's disease assessment scale, cognitive subscale and perfusion SPECT performed with 99Tc(m) hexamethylpropyleneamine oxime. Regions of interest were created for orbitofrontal cortices and basal ganglia. In 35 patients with AMB, adjusted tracer uptake was greater in the OFC. This reached statistical significance in right superior, left superior, right medial and left medial orbital gyri (p < 0.05). The association between AMB and hyperactivity in the OFC remained significant after adjusting for the presence of anxiety. These results parallel the OFC hypermetabolism consistently seen in OCD. One model of OCD, proposes that dysfunctional interactions between frontal regions, including the OFC, produce the characteristic symptoms of OCD. The behaviour is though to be brought about by a perceived incompleteness of performing a task and is caused by an error in normal reward signals initiated upon task completion. These finding indicate that AMB in Alzheimer's disease are brought about by the same mechanistic failure.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507335     DOI: 10.1016/j.bbr.2011.04.003

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.

Authors:  Noble George; Emily G Gean; Ayon Nandi; Boris Frolov; Eram Zaidi; Ho Lee; James R Brašić; Dean F Wong
Journal:  CNS Drugs       Date:  2015-04       Impact factor: 5.749

2.  The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study.

Authors:  Raquel Manso-Calderón; Purificación Cacabelos-Pérez; María D Sevillano-García; María E Herrero-Prieto; Rogelio González-Sarmiento
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

3.  Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease.

Authors:  Koichi Banno; Shutaro Nakaaki; Junko Sato; Katsuyoshi Torii; Jin Narumoto; Jun Miyata; Nobutsugu Hirono; Toshi A Furukawa; Masaru Mimura; Tatsuo Akechi
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-17       Impact factor: 2.570

4.  Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.

Authors:  Larisa V Lysenko; Jeesun Kim; Cassandra Henry; Anna Tyrtyshnaia; Rebecca A Kohnz; Francisco Madamba; Gabriel M Simon; Natalia E Kleschevnikova; Daniel K Nomura; R Alan B Ezekowitz; Alexander M Kleschevnikov
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

5.  Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.

Authors:  Syed Faraz Kazim; Julie Blanchard; Riccardo Bianchi; Khalid Iqbal
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

Review 6.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

7.  Balancing selection on CDH2 may be related to the behavioral features of the Belgian Malinois.

Authors:  Xue Cao; David M Irwin; Yan-Hu Liu; Lu-Guang Cheng; Lu Wang; Guo-Dong Wang; Ya-Ping Zhang
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.